Seok Bum Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Seok Bum Lee has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Joon Hyuk Park
Department of Psychiatry, Jeju National University School of Medicine, Jeju, Korea
14 shared publications - Ki Woong Kim
Seoul National University Bundang Hospital
14 shared publications - Bong-Jo Kim
Department of Psychiatry, Gyeongsang National University School of Medicine, Jinju, Republic of Korea
12 shared publications - Jeong Lan Kim
Department of Psychiatry, School of Medicine, Chungnam National University, Daejeon, South Korea
12 shared publications - Ji Won Han
Seoul National University Bundang Hospital
12 shared publications - Jin Hyeong Jhoo
Department of Psychiatry, College of Medicine, Kangwon National University, Chuncheon, Republic of Korea
12 shared publications
Latest Publications
- Open Access
- 2 October 2026
- Published by Springer Nature in Alzheimer's Research & Therapy
Criteria-based probable REM sleep behaviour disorder and risk of Lewy body dementia: analyses of a memory clinic cohort and a community cohort
Background: REM sleep behaviour disorder (RBD) is the strongest prodromal marker of alpha-synucleinopathies, but whether a brief questionnaire carries prognostic information for Lewy body dementia is unclear. We tested whether criteria-based probable RBD (pRBD)—a questionnaire algorithm requiring both core clinical features specified in the International Classification of Sleep Disorders, Third Edition (ICSD-3)—shows a subtype-specific association pattern, defined as an association with incident Lewy body dementia (LBD; dementia with Lewy bodies [DLB] or Parkinson’s disease dementia [PDD]) but not with all-cause dementia. Methods: Retrospective analysis of prospectively collected data from two independent cohorts—a memory clinic cohort ( n = 619; median follow-up 3.4 years) and the community-based Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD; n = 5274; 6.4 years). Criteria-based pRBD required dream-enactment behaviour (RBD Screening Questionnaire item 3) plus at least one complex nocturnal motor behaviour (items 6.1–6.3). Cause-specific hazard models estimated associations with incident LBD (clinic) and all-cause dementia (KLOSCAD), with the competing dementia subtype or death as competing events. Sensitivity analyses included inverse probability of censoring weighting, interval-censoring imputation and Firth-penalised estimation. Results: In the memory clinic, 34 of 619 patients (5.5%) screened positive, of whom 5 (14.7%) developed LBD compared with 21 of 585 (3.6%) who screened negative (cause-specific hazard ratio [HR] 4.82, 95% CI: 1.54–15.10); there was no association with all-cause dementia (HR 1.00, 95% CI: 0.57–1.76). Of the 26 LBD events, 23 were DLB and 3 were PDD. In KLOSCAD, pRBD was not associated with all-cause dementia (HR 0.92, 95% CI: 0.47–1.81). An exploratory KLOSCAD analysis based on only nine LBD events (6 DLB, 3 PDD) produced a large but very imprecise estimate (HR 8.99, 95% CI: 1.71–47.17) that is hypothesis-generating rather than replication. Conclusions: In memory clinic patients, criteria-based pRBD was associated with incident LBD but not with all-cause dementia. The community cohort showed no all-cause association. This subtype-specific profile supports further evaluation of the screen for prioritising alpha-synucleinopathy assessment, pending validation with polysomnography-confirmed RBD. These findings rest on 26 events in a cohort in which only a minority of registered patients returned, and require confirmation.
- 2 October 2026
- Published by Springer Nature in Alzheimer's Research & Therapy
Open AccessCriteria-based probable REM sleep behaviour disorder and risk of Lewy body dementia: analyses of a memory clinic cohort and a community cohort
Background: REM sleep behaviour disorder (RBD) is the strongest prodromal marker of alpha-synucleinopathies, but whether a brief questionnaire carries prognostic information for Lewy body dementia is unclear. We tested whether criteria-based probable RBD (pRBD)—a questionnaire algorithm requiring both core clinical features specified in the International Classification of Sleep Disorders, Third Edition (ICSD-3)—shows a subtype-specific association pattern, defined as an association with incident Lewy body dementia (LBD; dementia with Lewy bodies [DLB] or Parkinson’s disease dementia [PDD]) but not with all-cause dementia. Methods: Retrospective analysis of prospectively collected data from two independent cohorts—a memory clinic cohort ( n = 619; median follow-up 3.4 years) and the community-based Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD; n = 5274; 6.4 years). Criteria-based pRBD required dream-enactment behaviour (RBD Screening Questionnaire item 3) plus at least one complex nocturnal motor behaviour (items 6.1–6.3). Cause-specific hazard models estimated associations with incident LBD (clinic) and all-cause dementia (KLOSCAD), with the competing dementia subtype or death as competing events. Sensitivity analyses included inverse probability of censoring weighting, interval-censoring imputation and Firth-penalised estimation. Results: In the memory clinic, 34 of 619 patients (5.5%) screened positive, of whom 5 (14.7%) developed LBD compared with 21 of 585 (3.6%) who screened negative (cause-specific hazard ratio [HR] 4.82, 95% CI: 1.54–15.10); there was no association with all-cause dementia (HR 1.00, 95% CI: 0.57–1.76). Of the 26 LBD events, 23 were DLB and 3 were PDD. In KLOSCAD, pRBD was not associated with all-cause dementia (HR 0.92, 95% CI: 0.47–1.81). An exploratory KLOSCAD analysis based on only nine LBD events (6 DLB, 3 PDD) produced a large but very imprecise estimate (HR 8.99, 95% CI: 1.71–47.17) that is hypothesis-generating rather than replication. Conclusions: In memory clinic patients, criteria-based pRBD was associated with incident LBD but not with all-cause dementia. The community cohort showed no all-cause association. This subtype-specific profile supports further evaluation of the screen for prioritising alpha-synucleinopathy assessment, pending validation with polysomnography-confirmed RBD. These findings rest on 26 events in a cohort in which only a minority of registered patients returned, and require confirmation.
- Open Access
- 11 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Nanoparticle-enriched mass spectrometry enables comprehensive plasma proteomics and reveals novel candidates for mild cognitive impairment
Mild cognitive impairment (MCI) is a precursor to Alzheimer’s disease (AD), underscoring the need for reliable biomarkers for early identification. Here, we employed an automated nanoparticle-enrichment sample preparation platform combined with liquid chromatography–tandem mass spectrometry (LC–MS/MS) to facilitate comprehensive and unbiased detection of low-abundance proteins (LAPs). Through profiling of plasma proteomes from 42 individuals with MCI and 13 cognitively normal controls (NC), we identified 35 differentially expressed proteins (DEPs), of which four prioritized candidates were significantly correlated with Mini-Mental State Examination (MMSE) scores. Composite panels of candidate proteins showed potential to discriminate MCI, APOE4-carrier MCI, and amnestic MCI subtypes cases from NC, potentially providing insight into pathophysiological mechanisms underlying cognitive impairment. These findings highlight novel blood-based protein candidates uncovered by overcoming key limitations of conventional plasma proteomics, with potential to support MCI diagnosis.
- 11 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessNanoparticle-enriched mass spectrometry enables comprehensive plasma proteomics and reveals novel candidates for mild cognitive impairment
Mild cognitive impairment (MCI) is a precursor to Alzheimer’s disease (AD), underscoring the need for reliable biomarkers for early identification. Here, we employed an automated nanoparticle-enrichment sample preparation platform combined with liquid chromatography–tandem mass spectrometry (LC–MS/MS) to facilitate comprehensive and unbiased detection of low-abundance proteins (LAPs). Through profiling of plasma proteomes from 42 individuals with MCI and 13 cognitively normal controls (NC), we identified 35 differentially expressed proteins (DEPs), of which four prioritized candidates were significantly correlated with Mini-Mental State Examination (MMSE) scores. Composite panels of candidate proteins showed potential to discriminate MCI, APOE4-carrier MCI, and amnestic MCI subtypes cases from NC, potentially providing insight into pathophysiological mechanisms underlying cognitive impairment. These findings highlight novel blood-based protein candidates uncovered by overcoming key limitations of conventional plasma proteomics, with potential to support MCI diagnosis.
- Open Access
- 7 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 473
Revisiting the Geriatric Depression Scale: An IRT-Based 10-Item Screen Outperforms the GDS-15 in Diagnostic Accuracy and Efficiency
Background/Objective: Existing abbreviated Geriatric Depression Scales (GDSs), derived via Classical Test Theory (CTT), often sacrifice accuracy for brevity and retain non-specific items. We aimed to develop a minimum-item GDS maintaining diagnostic performance equivalent to the full 30-item scale (GDS30) using Item Response Theory (IRT). Methods: This cross-sectional study employed rigorous 5:5 split-sample cross-validation. Participants included 6525 older adults (aged ≥60 years) from community-based (Korean Longitudinal Study on Cognitive Aging and Dementia) and clinical settings (geropsychiatry clinic). Depression was diagnosed through standardized clinical interviews based on DSM-IV criteria. Two-parameter logistic IRT models estimated item discrimination and difficulty parameters. Sequential item reduction with DeLong tests identified the minimum number of items required to maintain GDS30-equivalent area under the curve (AUC). Results: The 10-item IRT-optimized scale (GDS10-IRT) achieved an AUC of 0.856 (95% CI: 0.809–0.895) in the validation set, showing no significant difference from GDS30 (AUC = 0.883; p = 0.396). Conversely, the 15-item GDS (GDS15) demonstrated significantly lower AUC than GDS30 (p < 0.001) despite having more items. GDS10-IRT achieved a 234% improvement in efficiency ratio (AUC/items) over GDS30. Notably, Item 16 (“feeling downhearted and blue”), identified as the most discriminating symptom (a = 2.53), is absent from the GDS15 but included in GDS10-IRT. Conclusions: IRT-based item selection achieves GDS30-equivalent diagnostic accuracy with only 10 items, outperforming the widely used GDS15. By recovering high-discrimination items excluded by CTT, the GDS10-IRT offers a more efficient, specific screening tool for late-life depression.
- 7 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 473
Open AccessRevisiting the Geriatric Depression Scale: An IRT-Based 10-Item Screen Outperforms the GDS-15 in Diagnostic Accuracy and Efficiency
Background/Objective: Existing abbreviated Geriatric Depression Scales (GDSs), derived via Classical Test Theory (CTT), often sacrifice accuracy for brevity and retain non-specific items. We aimed to develop a minimum-item GDS maintaining diagnostic performance equivalent to the full 30-item scale (GDS30) using Item Response Theory (IRT). Methods: This cross-sectional study employed rigorous 5:5 split-sample cross-validation. Participants included 6525 older adults (aged ≥60 years) from community-based (Korean Longitudinal Study on Cognitive Aging and Dementia) and clinical settings (geropsychiatry clinic). Depression was diagnosed through standardized clinical interviews based on DSM-IV criteria. Two-parameter logistic IRT models estimated item discrimination and difficulty parameters. Sequential item reduction with DeLong tests identified the minimum number of items required to maintain GDS30-equivalent area under the curve (AUC). Results: The 10-item IRT-optimized scale (GDS10-IRT) achieved an AUC of 0.856 (95% CI: 0.809–0.895) in the validation set, showing no significant difference from GDS30 (AUC = 0.883; p = 0.396). Conversely, the 15-item GDS (GDS15) demonstrated significantly lower AUC than GDS30 (p < 0.001) despite having more items. GDS10-IRT achieved a 234% improvement in efficiency ratio (AUC/items) over GDS30. Notably, Item 16 (“feeling downhearted and blue”), identified as the most discriminating symptom (a = 2.53), is absent from the GDS15 but included in GDS10-IRT. Conclusions: IRT-based item selection achieves GDS30-equivalent diagnostic accuracy with only 10 items, outperforming the widely used GDS15. By recovering high-discrimination items excluded by CTT, the GDS10-IRT offers a more efficient, specific screening tool for late-life depression.
- Open Access
- 16 December 2025
- Published by MDPI AG in Preprints.org
Revisiting the Geriatric Depression Scale: An IRT-Based 10-Item Screen Outperforms the GDS-15 in Diagnostic Accuracy and Efficiency
Background/Objective: Existing abbreviated Geriatric Depression Scales (GDS), derived via Classical Test Theory (CTT), often sacrifice accuracy for brevity and retain non-specific items. We aimed to develop a minimum-item GDS maintaining diagnostic performance equivalent to the full 30-item scale (GDS30) using Item Response Theory (IRT). Methods: This cross-sectional study employed rigorous 5:5 split-sample cross-validation. Participants included 6,525 older adults (aged ≥60 years) from community-based (Korean Longitudinal Study on Cognitive Aging and Dementia) and clinical settings (geropsychiatry clinic). Depression was diagnosed through standardized clinical interviews based on DSM-IV criteria. Two-parameter logistic IRT models estimated item discrimination and difficulty parameters. Sequential item reduction with DeLong tests identified the minimum number of items required to maintain GDS30-equivalent area under the curve (AUC). Results: The 10-item IRT-optimized scale (GDS10-IRT) achieved an AUC of 0.856 (95% CI: 0.809–0.895) in the validation set, showing no significant difference from GDS30 (AUC=0.883; p=0.396). Conversely, the 15-item GDS (GDS15) demonstrated significantly lower AUC than GDS30 (p< 0.001) despite having more items. GDS10-IRT achieved a 234% improvement in efficiency ratio (AUC/items) over GDS30. Notably, Item 16 ("feeling downhearted and blue"), identified as the most discriminating symptom (a=2.53), is absent from the GDS15 but included in GDS10-IRT. Conclusion: IRT-based item selection achieves GDS30-equivalent diagnostic accuracy with only 10 items, outperforming the widely used GDS15. By recovering high-discrimination items excluded by CTT, the GDS10-IRT offers a more efficient, specific screening tool for late-life depression.
- 16 December 2025
- Published by MDPI AG in Preprints.org
Open AccessRevisiting the Geriatric Depression Scale: An IRT-Based 10-Item Screen Outperforms the GDS-15 in Diagnostic Accuracy and Efficiency
Background/Objective: Existing abbreviated Geriatric Depression Scales (GDS), derived via Classical Test Theory (CTT), often sacrifice accuracy for brevity and retain non-specific items. We aimed to develop a minimum-item GDS maintaining diagnostic performance equivalent to the full 30-item scale (GDS30) using Item Response Theory (IRT). Methods: This cross-sectional study employed rigorous 5:5 split-sample cross-validation. Participants included 6,525 older adults (aged ≥60 years) from community-based (Korean Longitudinal Study on Cognitive Aging and Dementia) and clinical settings (geropsychiatry clinic). Depression was diagnosed through standardized clinical interviews based on DSM-IV criteria. Two-parameter logistic IRT models estimated item discrimination and difficulty parameters. Sequential item reduction with DeLong tests identified the minimum number of items required to maintain GDS30-equivalent area under the curve (AUC). Results: The 10-item IRT-optimized scale (GDS10-IRT) achieved an AUC of 0.856 (95% CI: 0.809–0.895) in the validation set, showing no significant difference from GDS30 (AUC=0.883; p=0.396). Conversely, the 15-item GDS (GDS15) demonstrated significantly lower AUC than GDS30 (p< 0.001) despite having more items. GDS10-IRT achieved a 234% improvement in efficiency ratio (AUC/items) over GDS30. Notably, Item 16 ("feeling downhearted and blue"), identified as the most discriminating symptom (a=2.53), is absent from the GDS15 but included in GDS10-IRT. Conclusion: IRT-based item selection achieves GDS30-equivalent diagnostic accuracy with only 10 items, outperforming the widely used GDS15. By recovering high-discrimination items excluded by CTT, the GDS10-IRT offers a more efficient, specific screening tool for late-life depression.
- Open Access
- 30 June 2025
- Published by The Korean Geriatrics Society in Annals of Geriatric Medicine and Research
- Vol. 29 (2) , 143-158
Evaluation of Activities of Daily Living: Current Insights and Future Horizons
Activities of daily living (ADL) assessments are crucial for evaluating functional independence and formulating care strategies for older adults. However, the existing tools encounter challenges, including cultural bias, subjectivity, and limited sensitivity to subtle changes in functional abilities. This review examines these limitations across basic, instrumental, and extended ADL categories and explores the integration of emerging technologies, such as artificial intelligence, sensor-based systems, and remote monitoring tools, to address these gaps. Technological advancements have the potential to enhance the accuracy, efficiency, and inclusivity of ADL assessment by providing objective data, supporting real-time evaluations, and enabling personalized care plans. By bridging the gap between traditional methods and innovative technologies, this review highlights a pathway for more equitable and effective assessments, ensuring that older adults across diverse contexts receive tailored support to maintain their independence and improve their quality of life.
- 30 June 2025
- Published by The Korean Geriatrics Society in Annals of Geriatric Medicine and Research
- Vol. 29 (2) , 143-158
Open AccessEvaluation of Activities of Daily Living: Current Insights and Future Horizons
Activities of daily living (ADL) assessments are crucial for evaluating functional independence and formulating care strategies for older adults. However, the existing tools encounter challenges, including cultural bias, subjectivity, and limited sensitivity to subtle changes in functional abilities. This review examines these limitations across basic, instrumental, and extended ADL categories and explores the integration of emerging technologies, such as artificial intelligence, sensor-based systems, and remote monitoring tools, to address these gaps. Technological advancements have the potential to enhance the accuracy, efficiency, and inclusivity of ADL assessment by providing objective data, supporting real-time evaluations, and enabling personalized care plans. By bridging the gap between traditional methods and innovative technologies, this review highlights a pathway for more equitable and effective assessments, ensuring that older adults across diverse contexts receive tailored support to maintain their independence and improve their quality of life.
- 8 May 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 106 (1) , 280-292
A sleep-based risk model for predicting dementia: Development and validation in a Korean cohort
Background: Dementia is a major public health challenge, yet existing prediction models often overlook sleep-related symptoms, despite their known links to cognitive decline. Objective: To develop and validate a four-year Dementia Risk Score (DRS) incorporating self-reported sleep-related symptoms with demographic and clinical factors to predict all-cause dementia, including Alzheimer's disease. Methods: Data from 3082 Korean adults aged 60–79 years were analyzed. Predictors were selected using LASSO regression and included in a multivariate logistic regression model. A point-based scoring system, the DRS, was constructed from the model coefficients. Internal validation was conducted using bootstrapping and a separate dataset. Results: The DRS achieved robust predictive performance, with AUC values of 0.824 in the training set and 0.826 in the validation set. Key predictors included sleep disturbance, use of sleep medications, daytime dysfunction, leg discomfort, and urge to move legs. Conclusions: The DRS provides a practical, scalable tool for predicting dementia risk, supporting community-based screening and early intervention. External validation is needed to confirm its broader applicability.
- 8 May 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 106 (1) , 280-292
A sleep-based risk model for predicting dementia: Development and validation in a Korean cohort
Background: Dementia is a major public health challenge, yet existing prediction models often overlook sleep-related symptoms, despite their known links to cognitive decline. Objective: To develop and validate a four-year Dementia Risk Score (DRS) incorporating self-reported sleep-related symptoms with demographic and clinical factors to predict all-cause dementia, including Alzheimer's disease. Methods: Data from 3082 Korean adults aged 60–79 years were analyzed. Predictors were selected using LASSO regression and included in a multivariate logistic regression model. A point-based scoring system, the DRS, was constructed from the model coefficients. Internal validation was conducted using bootstrapping and a separate dataset. Results: The DRS achieved robust predictive performance, with AUC values of 0.824 in the training set and 0.826 in the validation set. Key predictors included sleep disturbance, use of sleep medications, daytime dysfunction, leg discomfort, and urge to move legs. Conclusions: The DRS provides a practical, scalable tool for predicting dementia risk, supporting community-based screening and early intervention. External validation is needed to confirm its broader applicability.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (45) , e326
Refining Western Dementia-Risk Paradigms: Evidence From a Decade of the Korean Longitudinal Study on Cognitive Aging and Dementia
Han JW, et al. J Korean Med Sci. 2025 Nov;40(45):e326. https://doi.org/10.3346/jkms.2025.40.e326
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (45) , e326
Open AccessRefining Western Dementia-Risk Paradigms: Evidence From a Decade of the Korean Longitudinal Study on Cognitive Aging and Dementia
Han JW, et al. J Korean Med Sci. 2025 Nov;40(45):e326. https://doi.org/10.3346/jkms.2025.40.e326
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (36) , e246
Masticatory Function, Sex, and Risk of Dementia Among Older Adults: A Population-Based Cohort Study
Oh DJ, et al. J Korean Med Sci. 2024 Jul;39:e246. https://doi.org/10.3346/jkms.2024.39.e246
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (36) , e246
Open AccessMasticatory Function, Sex, and Risk of Dementia Among Older Adults: A Population-Based Cohort Study
Oh DJ, et al. J Korean Med Sci. 2024 Jul;39:e246. https://doi.org/10.3346/jkms.2024.39.e246
- 31 October 2023
- Published by Korean Association for Geriatric Psychiatry in Korean Association for Geriatric Psychiatry
- Vol. 27 (2) , 71-77
Effects of Group Reminiscence Therapy Based on Korean Traditional Play for Mild Cognitive Impairment and Dementia Patients
Objective: This study explored the efficacy of group reminiscence therapy, incorporating traditional plays, for individuals with mild cognitive impairment (MCI) and dementia patients. Methods: We provided 10 sessions of group reminiscence therapy to 25 MCI and dementia patients. We conducted assessments, both before and after the program, encompassing a range of tests, namely the Mini-Mental Status Examination (MMSE), Dysexecutive Questionnaire, Zarit Burden Interview (ZBI-K), Dementia Care Assessment Packet-Instrumental Activities of Daily Living, Geriatric Depression Scale (GDS-K), and Neuropsychiatric Inventory (NPI-K). Results: Following the program, there was a significant improvement in MMSE scores for MCI patients (19.17 to 22.33, p=0.027). There was a significant improvement in NPI-K scores for dementia patients (8.05 to 3.74, p=0.006). There was a significant improvement in GDS-K scores for MCI patients (17.00 to 14.00, p=0.043). There was a significant improvement in ZBIK scores for dementia (28.53 to 17.68, p=0.001) and MCI patients (29.17 to 16.33, p=0.046). Conclusion: Our study suggested that group reminiscence therapy based on traditional play might be effective in global cognition of MCI patients, neuropsychological symptoms of dementia patients, depression of MCI patients, and caregiver burden of all subjects.
- 31 October 2023
- Published by Korean Association for Geriatric Psychiatry in Korean Association for Geriatric Psychiatry
- Vol. 27 (2) , 71-77
Effects of Group Reminiscence Therapy Based on Korean Traditional Play for Mild Cognitive Impairment and Dementia Patients
Objective: This study explored the efficacy of group reminiscence therapy, incorporating traditional plays, for individuals with mild cognitive impairment (MCI) and dementia patients. Methods: We provided 10 sessions of group reminiscence therapy to 25 MCI and dementia patients. We conducted assessments, both before and after the program, encompassing a range of tests, namely the Mini-Mental Status Examination (MMSE), Dysexecutive Questionnaire, Zarit Burden Interview (ZBI-K), Dementia Care Assessment Packet-Instrumental Activities of Daily Living, Geriatric Depression Scale (GDS-K), and Neuropsychiatric Inventory (NPI-K). Results: Following the program, there was a significant improvement in MMSE scores for MCI patients (19.17 to 22.33, p=0.027). There was a significant improvement in NPI-K scores for dementia patients (8.05 to 3.74, p=0.006). There was a significant improvement in GDS-K scores for MCI patients (17.00 to 14.00, p=0.043). There was a significant improvement in ZBIK scores for dementia (28.53 to 17.68, p=0.001) and MCI patients (29.17 to 16.33, p=0.046). Conclusion: Our study suggested that group reminiscence therapy based on traditional play might be effective in global cognition of MCI patients, neuropsychological symptoms of dementia patients, depression of MCI patients, and caregiver burden of all subjects.
- Open Access
- 14 July 2023
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 21 (4) , 758-768
A Preliminary Study on the Potential Protective Role of the Antioxidative Stress Markers of Cognitive Impairment: Glutathione and Glutathione Reductase
Sang-a Park, Gihwan Byeon, Jin Hyeong Jhoo, Hyung-Chun Kim, Myoung-Nam Lim, Jae-Won Jang, Jong Bin Bae, Ji Won Han, Tae Hui Kim, Kyung Phil Kwak, Bong Jo Kim, Shin Gyeom Kim, Jeong Lan Kim, Seok Woo Moon, Joon Hyuk Park, Seung-Ho Ryu, Jong Chul Youn, Dong Woo Lee, Seok Bum Lee, Jung Jae Lee, Dong Young Lee, Ki Woong Kim. Clin Psychopharmacol Neurosci -0001;0:. https://doi.org/10.9758/cpn.23.1053
- 14 July 2023
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 21 (4) , 758-768
Open AccessA Preliminary Study on the Potential Protective Role of the Antioxidative Stress Markers of Cognitive Impairment: Glutathione and Glutathione Reductase
Sang-a Park, Gihwan Byeon, Jin Hyeong Jhoo, Hyung-Chun Kim, Myoung-Nam Lim, Jae-Won Jang, Jong Bin Bae, Ji Won Han, Tae Hui Kim, Kyung Phil Kwak, Bong Jo Kim, Shin Gyeom Kim, Jeong Lan Kim, Seok Woo Moon, Joon Hyuk Park, Seung-Ho Ryu, Jong Chul Youn, Dong Woo Lee, Seok Bum Lee, Jung Jae Lee, Dong Young Lee, Ki Woong Kim. Clin Psychopharmacol Neurosci -0001;0:. https://doi.org/10.9758/cpn.23.1053